This Article Full Text Full Text (PDF) CME: Take the course for this article: Stroke: February 2009, Volume 40, Number 2 All Versions of this Article: 40/2/505    most recent STROKEAHA.108.528281v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Turan, T. N. Search for Related Content PubMed PubMed Citation Articles by Turan, T. N. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLSALICYLIC ACID WARFARIN Medline Plus Health Information Stroke Related Collections Secondary prevention Other arteriosclerosis Coumarins Other anticoagulants Risk Factors for Stroke Anticoagulants Antiplatelets

(Stroke. 2009;40:505.)
© 2009 American Heart Association, Inc.

Original Contributions

Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial Stenosis

Tanya N. Turan, MD; Lucian Maidan, MD; George Cotsonis, MA; Michael J. Lynn, MS; Jose G. Romano, MD; Steven R. Levine, MD; Marc I. Chimowitz, MBChB for the WASID Investigators

From the Medical University of South Carolina (T.N.T., M.I.C.), Charleston, SC; Emory University (L.M., G.C., M.J.L.), Atlanta, Ga; the University of Miami (J.G.R.), Miami, Fla; and Mount Sinai School of Medicine (S.R.L.), New York, NY.

Correspondence to Tanya N. Turan, MD, Assistant Professor of Neurology, MUSC Stroke Program, Department of Neurosciences, 19 Hagood Ave, Harborview Office Tower, Suite 501, Charleston, SC 29425. E-mail turan{at}musc.edu

Background and Purpose— We sought to determine if patients with intracranial stenosis who have a transient ischemic attack or stroke on antithrombotic therapy are at particularly high risk for recurrent stroke.

Methods— We compared baseline features and the rates of stroke or vascular death and stroke in the territory of the symptomatic artery between patients ON (n=299) versus OFF (n=269) antithrombotics at the time of their qualifying event for the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial.

Results— In univariate analyses, there was no difference in the rates of stroke or vascular death (21% versus 23%; hazard ratio [ON/OFF], 0.91; 95% CI, 0.64 to 1.29; P=0.59) or stroke in territory (13% versus 14%; hazard ratio [ON/OFF], 0.90; 95% CI, 0.57 to 1.39; P=0.61) between patients ON versus OFF antithrombotics at the time of their qualifying event. A multivariable analysis adjusted for the difference in risk factors between patients ON and OFF antithrombotic therapy also showed no significant differences in the combined end point of stroke or vascular death (hazard ratio [ON/OFF], 0.86; 95% CI, 0.55 to 1.34; P=0.51) or stroke in territory (hazard ratio [ON/OFF], 1.01; 95% CI, 0.58 to 1.77; P=0.97) between patients ON versus OFF antithrombotic therapy at the time of the qualifying event.

Conclusions— Patients with intracranial stenosis who fail antithrombotic therapy are not at higher risk of stroke than those who do not fail antithrombotic therapy. Given our finding that patients ON and OFF antithrombotic therapy are both at high risk for stroke in the territory, intracranial stenting trials should not be limited to just those who fail antithrombotic therapy.

Key Words: anticoagulation • antiplatelet • cerebral arteries • cerebrovascular disease • intracranial stenosis

This article has been cited by other articles:

				D Fiorella, T N Turan, C P Derdeyn, and M I Chimowitz Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting JNIS, July 3, 2009; (2009) jnis.2009.000125v1. [Abstract] [Full Text] [PDF]

				T. N. Turan, C. P. Derdeyn, D. Fiorella, and M. I. Chimowitz Treatment of Atherosclerotic Intracranial Arterial Stenosis Stroke, June 1, 2009; 40(6): 2257 - 2261. [Full Text] [PDF]